Skip to main content
DIRUI INDUSTRIAL CO.,LTD. logo

DIRUI INDUSTRIAL CO.,LTD. — Investor Relations & Filings

Ticker · 300396 ISIN · CNE100001XS7 Shenzhen Stock Exchange Manufacturing
Filings indexed 1,689 across all filing types
Latest filing 2023-12-07 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300396

About DIRUI INDUSTRIAL CO.,LTD.

https://www.dirui.com.cn

DIRUI INDUSTRIAL CO.,LTD. specializes in the research, development, manufacturing, and distribution of medical laboratory instruments and diagnostic reagents. The company provides comprehensive solutions for in-vitro diagnostics (IVD), focusing on several key clinical areas including urinalysis, biochemistry, hematology, and chemiluminescence immunoassay. Its product portfolio features high-throughput automated analyzers and integrated laboratory systems designed to enhance diagnostic efficiency and accuracy. DIRUI serves a global market, providing medical institutions and laboratories with a wide range of diagnostic tools, from urine sediment analysis to vaginal secretion testing. The company emphasizes technological innovation and quality control to support clinical decision-making and patient care through reliable laboratory automation and standardized testing protocols.

Recent filings

Filing Released Lang Actions
独立董事提名人声明与承诺(余宇莹)
Board/Management Information Classification · 95% confidence The document is a formal statement from the board of directors nominating an individual as an independent director candidate. It includes detailed declarations and commitments regarding the nominee's qualifications, independence, and compliance with relevant laws and regulations. There are no financial statements, earnings data, or report attachments. The content is focused on board/management information, specifically about director nomination and related compliance. The document length is 3209 characters, which is relatively short and consistent with a nomination statement rather than a full report. Therefore, the document fits best under the category of Board/Management Information (MANG).
2023-12-07 Chinese
内部审计制度
Governance Information Classification · 95% confidence The document is titled '内部审计制度' (Internal Audit System) of 迪瑞医疗科技股份有限公司 and details the company's internal audit policies, responsibilities, procedures, and organizational structure. It references relevant laws and regulations, outlines the duties of the audit department, and describes internal control evaluation and reporting processes. The document is a policy or procedural manual rather than a financial report, audit report, or announcement. It does not contain financial statements, audit opinions, or results of audits but rather sets out the internal audit framework and governance. Given its nature as an internal audit system document, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices. The document length is under 5,000 characters, but it is not an announcement of a report publication; it is the policy document itself. Therefore, the appropriate classification is CGR with high confidence.
2023-12-07 Chinese
投资者关系管理制度
Governance Information Classification · 95% confidence The document is titled '投资者关系管理制度' which translates to 'Investor Relations Management System'. It is a detailed policy document outlining the company's investor relations management practices, principles, responsibilities, and procedures. It includes sections on communication with investors, compliance with laws and regulations, investor meetings, and internal controls related to investor relations. There are no financial statements, earnings data, or audit information present. The document is not an announcement or a brief summary but a comprehensive governance and procedural manual related to investor relations. This fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices. The document is 9768 characters long, indicating it is a full policy document rather than a short announcement or notice.
2023-12-07 Chinese
关于第五届董事会第十一次会议相关事项的独立董事意见
Board/Management Information Classification · 95% confidence The document is an independent opinion statement from the independent directors of a company regarding matters discussed at the eleventh meeting of the fifth board of directors. It includes opinions on the board re-election and nomination of new board members, as well as approval of a capital reduction proposal. The content focuses on governance and board-related matters, with no financial statements or earnings data. It is not a full annual or interim report, nor an earnings release or audit report. It is not a simple announcement but a detailed opinion related to board and management changes and governance. Therefore, the document fits best under Board/Management Information (MANG). The document length is short and specific to board matters, confirming this classification.
2023-12-07 Chinese
规范与关联方资金往来的管理制度
Governance Information Classification · 95% confidence The document is titled as a management system or policy document regarding the management of funds and transactions between the company and its related parties. It outlines rules, responsibilities, and procedures to prevent misuse of company funds by related parties. There are no financial statements, audit results, or financial performance data presented. The document is a governance-related internal policy rather than a financial report, announcement, or regulatory filing. It does not fit into categories like Annual Report, Audit Report, Earnings Release, or Capital Update. It is best classified under Governance Information (CGR) as it details internal rules and governance practices related to related party transactions and fund management.
2023-12-07 Chinese
特定对象来访接待制度
Governance Information Classification · 95% confidence The document is a detailed internal policy document titled '特定对象来访接待制度' (Specific Object Visit Reception System) issued by 迪瑞医疗科技股份有限公司. It outlines the principles, procedures, and responsibilities related to the company's reception and communication with specific external parties such as investors, analysts, media, and shareholders. The content focuses on compliance with securities laws, fair disclosure, confidentiality, and investor relations management. It does not contain financial statements, audit opinions, earnings data, or any form of financial results. It is not a report, announcement of voting results, nor a regulatory filing in the usual sense. Instead, it is a governance-related document detailing internal rules and procedures for managing investor relations and information disclosure. Therefore, the most appropriate classification is Governance Information (CGR). The document length (4630 characters) and content confirm it is a substantive policy document, not a brief announcement or certification.
2023-12-07 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.